Application

19621911 · Recombinant Fusion Protein Targeting CD38 and CD47

Filed 2026-09-07 · Pending The official file ↗ · Art unit · ImmuneOnco Biopharmaceuticals (Shanghai) Inc. · BENJAMIN A. ADLER

Office actions

first was

RCEs

no appeal

To first action

n/a

to disposition n/a

Statutes raised

0 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.